Recombinant Hostilia carinata Pyrokinin-5

What is Recombinant Hostilia carinata Pyrokinin-5?

Recombinant Hostilia carinata Pyrokinin-5 (HosCa-Capa-PK) is a FXPRL-amide neuropeptide originally identified in the cockroach Hostilia carinata, now produced through recombinant expression systems. The 17-amino acid peptide belongs to the pyrokinin family of neuropeptides found across various insect species. Recombinant versions of this peptide are valuable tools in studying neuropeptide signaling systems and their physiological functions in insects. The protein is typically expressed in prokaryotic (E.coli) or eukaryotic (yeast, baculovirus, mammalian cell) expression systems, allowing researchers to obtain sufficient quantities for functional and structural studies .

What is the precise amino acid sequence of Hostilia carinata Pyrokinin-5?

The amino acid sequence of Hostilia carinata Pyrokinin-5 is SGETSGEGNG MWFGPRL. This sequence has been confirmed through protein sequencing analysis and is available in protein databases under UniProt accession number P85796 . The sequence includes the characteristic C-terminal FXPRL-amide motif common to pyrokinins, which is critical for receptor binding and biological activity. When comparing with similar pyrokinins from other cockroach species, there are notable similarities. For instance, Pea-PK-5 from the American cockroach has the sequence GGGGSGETSGMWFGPRL-NH2, showing conservation especially in the C-terminal region that is crucial for biological activity .

How do pyrokinins function in insect physiology?

Pyrokinins function as neuropeptide signaling molecules that interact with G protein-coupled receptors (GPCRs) to regulate various physiological processes in insects. These peptides are produced in neurohemal organs and released into the hemolymph to act on target tissues. Different pyrokinin isoforms can exhibit varied distribution patterns across neurohemal organs, suggesting specialized functions. For example, in the American cockroach, Pea-PK-3, Pea-PK-4, and Pea-PK-5 have been isolated from different neurohemal organs and show dramatically different threshold concentrations for eliciting muscle contractions . Research in the brown marmorated stink bug (Halyomorpha halys) has revealed that pyrokinin receptors demonstrate tissue-specific expression patterns, with some receptors predominantly expressed in the central nervous system, Malpighian tubules, or other tissues, further supporting the specialized roles of pyrokinins in different physiological processes .

What are the optimal conditions for reconstitution and storage of Recombinant Hostilia carinata Pyrokinin-5?

For optimal reconstitution of lyophilized Recombinant Hostilia carinata Pyrokinin-5, researchers should first briefly centrifuge the vial to ensure all contents are at the bottom. The protein should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Addition of glycerol to a final concentration of 5-50% (with 50% being commonly recommended) is advised for long-term storage stability. After reconstitution, the solution should be aliquoted to minimize freeze-thaw cycles .

For storage, the following protocols are recommended:

• Short-term (up to one week): Store working aliquots at 4°C

• Long-term: Store at -20°C or -80°C for extended preservation

• Avoid repeated freeze-thaw cycles as this significantly reduces protein activity

The shelf life of the reconstituted protein in liquid form is approximately 6 months at -20°C/-80°C, while the lyophilized form maintains stability for approximately 12 months when stored at -20°C/-80°C .

How can researchers effectively evaluate receptor binding and activation by Pyrokinin-5?

Evaluating receptor binding and activation by Pyrokinin-5 requires multiple complementary approaches:

• Cell-based functional assays: Researchers can employ heterologous expression systems where candidate pyrokinin receptors are expressed in cell lines (e.g., HEK293, CHO cells). The Brown Marmorated Stink Bug study demonstrates effective use of cell-based assays to characterize receptor responses to pyrokinin peptides. These assays typically measure second messenger production or other downstream signaling events upon receptor activation .

• Dose-response experiments: Serial dilutions of Pyrokinin-5 should be tested to determine EC50 values for receptor activation. This approach helps characterize receptor sensitivity and specificity, as demonstrated in the H. halys study where different receptor variants showed varying affinities for PK1 and PK2 peptides .

• Competitive binding assays: Using labeled (e.g., fluorescent or radiolabeled) pyrokinin peptides to measure displacement by unlabeled peptides can provide direct evidence of binding affinity.

• Receptor subtype profiling: Testing Pyrokinin-5 against multiple receptor subtypes helps determine specificity profiles. For example, in H. halys, six GPCRs including splice variants were characterized, showing different response profiles to pyrokinin and CAPA peptides .

What methods are appropriate for assessing the purity and integrity of Recombinant Hostilia carinata Pyrokinin-5?

Multiple analytical methods should be employed to assess the purity and integrity of Recombinant Hostilia carinata Pyrokinin-5:

• SDS-PAGE: Standard purity assessment method that can resolve proteins based on molecular weight. Commercial preparations typically specify a purity of >85% as determined by SDS-PAGE .

• Mass Spectrometry:

  • MALDI-TOF MS: For accurate molecular weight determination

  • LC-MS/MS: For sequence confirmation and identification of post-translational modifications

  • This approach was successfully used in structural elucidation of pyrokinins from the American cockroach

• HPLC Analysis:

  • Reverse-phase HPLC for purity assessment

  • Size-exclusion HPLC to detect aggregates or degradation products

• Functional Assays:

  • Bioactivity testing using appropriate cell-based assays to confirm that the recombinant protein retains functional activity

  • Comparison with synthetic peptide standards when available

• Western Blotting:

  • If antibodies are available, western blotting can confirm identity and assess degradation

Commercial preparations typically report purity levels of >85% by SDS-PAGE analysis, which provides a baseline quality standard for research applications .

How do structural variations between pyrokinin isoforms influence receptor binding specificity?

Structural variations between pyrokinin isoforms significantly influence receptor binding specificity and downstream signaling outcomes. Research data reveals these key principles:

What approaches can be used to identify and characterize novel GPCRs that respond to Pyrokinin-5?

Identification and characterization of novel GPCRs that respond to Pyrokinin-5 can be accomplished through multifaceted approaches:

• Genomic and transcriptomic mining: BLAST analysis of genomic and transcriptomic databases using known pyrokinin receptor sequences as queries can identify putative receptor genes. This approach was successfully employed in H. halys to identify six pyrokinin and CAPA receptors including splice variants .

• Cloning and heterologous expression: Candidate receptor sequences should be cloned and expressed in appropriate cell lines (HEK293, CHO) for functional testing. This allows for controlled evaluation of receptor-ligand interactions.

• Functional screening assays:

  • Second messenger assays (calcium mobilization, cAMP production)

  • Receptor internalization assays

  • β-arrestin recruitment assays

  • These can be used to screen libraries of orphan GPCRs for responses to Pyrokinin-5

• Tissue-specific expression analysis: RT-PCR and in situ hybridization can determine the expression patterns of identified receptors across tissues and developmental stages, providing insights into physiological roles. In H. halys, such analyses revealed tissue-specific expression patterns for different receptor subtypes, with some predominantly expressed in the CNS and others in the Malpighian tubules .

• Receptor variant identification: Analysis of alternative splicing can identify receptor variants with potentially different signaling properties, as demonstrated by the identification of splice variants HalhaPK-R1a & b and HalhaPK-R3a & b in H. halys .

How can Pyrokinin-5 research contribute to understanding evolutionary relationships of neuropeptide signaling across insect species?

Pyrokinin-5 research offers valuable insights into the evolutionary relationships of neuropeptide signaling systems across insect species through several approaches:

• Sequence conservation analysis: Comparative analysis of pyrokinin sequences across insect orders reveals patterns of conservation and divergence. The core FXPRL-amide motif shows strong conservation, while N-terminal regions display greater variability, suggesting differential selective pressures on functional domains.

• Receptor-ligand co-evolution: Studying how pyrokinin receptors and their ligands have co-evolved provides insights into signaling system adaptation. The H. halys study demonstrates how different receptor subtypes evolved varying specificities for PK1 and PK2 peptides, suggesting functional specialization during evolution .

• Tissue distribution patterns: The differential distribution of pyrokinin isoforms in neurohemal organs, as observed in the American cockroach, suggests evolutionary adaptations in the regulation of neuropeptide release and action. This was the first reported case of differential distribution of peptide isoforms in insect neurohemal organs .

• Developmental expression patterns: The finding that certain pyrokinin receptors in H. halys are dominantly expressed in the fifth nymph stage suggests stage-specific roles that may reflect evolutionary adaptations to developmental requirements .

• Cross-species functional conservation: Comparing the biological activities of pyrokinins across species can reveal functional conservation despite sequence divergence, highlighting essential signaling pathways maintained through evolutionary history.

How should researchers analyze dose-response data for pyrokinin receptor activation studies?

Analysis of dose-response data for pyrokinin receptor activation requires rigorous statistical approaches and careful interpretation:

• Curve fitting methodology:

  • Use nonlinear regression to fit dose-response data to appropriate models (four-parameter logistic model is standard)

  • Calculate EC50 (half-maximal effective concentration) values to compare potencies across different pyrokinins and receptor subtypes

  • Determine Emax (maximum effect) values to assess efficacy

• Replicate design considerations:

  • Minimum of three independent biological replicates

  • Multiple technical replicates within each biological replicate

  • Include positive controls (known agonists) and negative controls

• Statistical analysis:

  • Apply appropriate statistical tests to compare EC50 values (t-tests or ANOVA with post-hoc tests)

  • Calculate 95% confidence intervals for all parameters

  • Evaluate goodness-of-fit using R² values

• Data normalization strategies:

  • Normalize responses relative to maximum response or to a standard agonist

  • Consider baseline drift and account for it in calculations

• Interpretation guidelines:

  • Compare activation profiles across receptor subtypes (as demonstrated in the H. halys study where different receptor variants showed varying response patterns to PK1 and PK2 peptides)

  • Consider partial agonism versus full agonism

  • Evaluate potential receptor reserve effects

  • Assess structure-activity relationships by comparing responses to peptides with sequence variations

What bioinformatic approaches are most effective for analyzing pyrokinin sequences and predicting their functions?

Several bioinformatic approaches have proven effective for analyzing pyrokinin sequences and predicting their functions:

• Sequence alignment and motif analysis:

  • Multiple sequence alignment using MUSCLE or Clustal algorithms

  • Identification of conserved motifs using MEME or similar tools

  • Analysis of the C-terminal FXPRL-amide motif and variations that may affect receptor binding

• Homology modeling and structure prediction:

  • Ab initio modeling for short peptides like pyrokinins

  • Secondary structure prediction using programs like PSIPRED

  • Molecular dynamics simulations to predict peptide flexibility and conformational preferences

• Phylogenetic analysis:

  • Construction of phylogenetic trees to understand evolutionary relationships

  • Analysis of selection pressures on different regions of pyrokinin sequences

  • Identification of lineage-specific adaptations

• Receptor-ligand interaction prediction:

  • Molecular docking to predict binding modes

  • Binding site analysis of known pyrokinin receptors

  • Prediction of critical residues for interaction

• Expression pattern analysis:

  • Mining transcriptomic datasets to identify tissue-specific expression patterns

  • Analysis of co-expression networks to identify functionally related genes

  • Integration of expression data with phenotypic information, as demonstrated in the H. halys study where receptor expression was characterized across different tissues and developmental stages

• Cross-species comparative analysis:

  • Identification of orthologous sequences across species

  • Analysis of sequence conservation in relation to functional conservation

  • Prediction of functional divergence based on sequence variations